Scientific and Technical Advances in Cancer Immunology

Suzhou, China 
June 8-12, 2019 

Abstract deadline: April 19, 2019 

  Download Flyer

Schedule Overview

Conference Agenda

Organized by:

Ira Mellman, University of California San Francisco/Genentech, USA

Zemin Zhang, Peking University, China

We are pleased to announce the Cold Spring Harbor Asia conference on Scientific and Technical Advances in Cancer Immunology which will be held in Suzhou, China, located approximately 60 miles west of Shanghai. The conference will begin at 7:00pm on the evening of Saturday June 8, and will conclude after lunch on Wednesday June 12, 2019.

The conference will include eight oral sessions and one poster session covering the latest findings across many topics in Cancer Immunology. Many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions.

Major Topics:
1. Clinical advances in cancer immunotherapies
2. New target identification for cancer immunotherapies
3. T cell biology, checkpoint blockade, and CAR-T
4. The tumor microenvironment: imaging and cell-cell interaction
5. Myeloid cells and cancer
6. Single cell sequencing and tumor immunology
7. Tumor immunogenomics and large-scale biology

Keynote Speakers (Speaker, Affiliation, COUNTRY/Region):
Xuetao Cao, Nankai University, CHINA
Abstract title:Tumor-induced B cells and erythroblast-like cells (Ter-cells) in pre-metastatic niche formation and cancer metastasis|
Alexander Rudensky, Memorial Sloan Kettering Cancer Center, USA
Abstract title:Regulatory T cells in cancer

Invited Speakers (Speaker, Affiliation, COUNTRY/Region):
Tara Arvedson, Oncology Research, Amgen, USA
Abstract title:eva1uation of BiTE® antibody constructs in hematological malignancies and solid tumors 
Sebastian Carotta, Boehringer Ingelheim, Austria
Abstract title:Identification of novel key regulators of natural killer cell activation 
Chen Dong, Tsinghua University, CHINA
Abstract title:Molecular control of T cell function in cancer 
Yang-Xin Fu, UT Southwestern Medical Center, USA
Abstract title:Tumor-targeting immunotherapy—Enhanced anti-tumor efficacy with reduced toxicity 
Ronald Germain, National Institutes of Health, USA
Abstract title:Imaging immunity in many colors and dimensions—Developing a detailed spatiotemporal understanding of host defense 
Abstract title:Macrophage and Dendritic Cell Biology 
Muzlifah Haniffa, Newcastle University, UK
Abstract title:Reconstructing the human immune system using single cell technologies 
Vijay Kuchroo, Harvard Medical School & Brigham and Women's Hospital, USA
Abstract title:Induction and transcriptional regulation of the “check-point” molecules in T cells 
Ira Mellman, University of California, San Francisco/Genentech, USA
Abstract title:Mechanistic basis of cancer immunotherapy 
Wenjun Ouyang, Amgen, USA
Abstract title:Dissecting the mechanisms of IO therapies by single cell RNAseq 
Woong-Yang Park, Samsung Medical Center, South Korea
Abstract title:Re-wiring inter-cellular interactions in colon cancer 
Shyam Prabhakar, Genome Institute of Singapore, SINGAPORE
Abstract title:Algorithms for single cell analysis of immune cells 
Hai Qi, Tsinghua University, CHINA
Abstract title:Inflammatory tissue tropism of virtual memory T cells enables an extra-lymphoid primary response
Bing Su, Shanghai Jiao Tong University School of Medicine, China
Abstract title:Targeting mTOR Complex for Anti-tumor Growth and Immunity 
Eric Tran, Providence Portland Medical Center, USA
Abstract title:Targeting cancer neoantigens with T-cell transfer therapy 
Jun Wang, Yale University, USA
Abstract title:Tumor-site immune modulation—Target discovery for nextgeneration cancer immunotherapy 
E. John Wherry, University of Pennsylvania, USA
Abstract title:Molecular mechanisms of T cell exhaustion and implications for immunotherapy 
Meng Michelle Xu, Tsinghua University, CHINA
Abstract title:Anti-tumor immunity controlled through mRNA m6A program 
Nir Yosef, University of California, Berkeley, USA
Abstract title:Cell-specific metabolic models reveal targets that mitigate pathogenicity in T helper cells 
Zemin Zhang, Peking University, CHINA
Abstract title:Dynamic properties of tumor-infiltrating immune cells revealed by single cell sequencing 
Zhixin Zhang, Sichuan University, CHINA
Abstract title:Using BCR/TCR diversity eva1uates immune system and directs immune cell therapy 
Penghui Zhou, Sun Yat-Sen University Cancer Center, CHINA
Abstract title:DGKA mediates resistance to PD-1 blockade 

We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (fellow's talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers. 

We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of presentations by graduate students and postdocs in this conference will be selected as fellowship (USD $100-$500) awards. For more details, please visit

We look forward to seeing you at Suzhou in June, 2019.

Sponsored by: